801 related articles for article (PubMed ID: 22313874)
1. Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression.
Ostrand-Rosenberg S; Sinha P; Beury DW; Clements VK
Semin Cancer Biol; 2012 Aug; 22(4):275-81. PubMed ID: 22313874
[TBL] [Abstract][Full Text] [Related]
2. Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.
Parker KH; Beury DW; Ostrand-Rosenberg S
Adv Cancer Res; 2015; 128():95-139. PubMed ID: 26216631
[TBL] [Abstract][Full Text] [Related]
3. Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses.
Hossain F; Majumder S; Ucar DA; Rodriguez PC; Golde TE; Minter LM; Osborne BA; Miele L
Front Immunol; 2018; 9():1288. PubMed ID: 29915603
[TBL] [Abstract][Full Text] [Related]
4. Allies or Enemies-The Multifaceted Role of Myeloid Cells in the Tumor Microenvironment.
Haas L; Obenauf AC
Front Immunol; 2019; 10():2746. PubMed ID: 31849950
[TBL] [Abstract][Full Text] [Related]
5. Myeloid cells as orchestrators of the tumor microenvironment: novel targets for nanoparticular cancer therapy.
Tuettenberg A; Steinbrink K; Schuppan D
Nanomedicine (Lond); 2016 Oct; 11(20):2735-2751. PubMed ID: 27658725
[TBL] [Abstract][Full Text] [Related]
6. Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment.
Ostrand-Rosenberg S; Fenselau C
J Immunol; 2018 Jan; 200(2):422-431. PubMed ID: 29311384
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-inducible factors in regulation of immune responses in tumour microenvironment.
Kumar V; Gabrilovich DI
Immunology; 2014 Dec; 143(4):512-9. PubMed ID: 25196648
[TBL] [Abstract][Full Text] [Related]
8. Myeloid-derived suppressor cell function is reduced by Withaferin A, a potent and abundant component of Withania somnifera root extract.
Sinha P; Ostrand-Rosenberg S
Cancer Immunol Immunother; 2013 Nov; 62(11):1663-73. PubMed ID: 23982485
[TBL] [Abstract][Full Text] [Related]
9. β-glucan restores tumor-educated dendritic cell maturation to enhance antitumor immune responses.
Ning Y; Xu D; Zhang X; Bai Y; Ding J; Feng T; Wang S; Xu N; Qian K; Wang Y; Qi C
Int J Cancer; 2016 Jun; 138(11):2713-23. PubMed ID: 26773960
[TBL] [Abstract][Full Text] [Related]
10. Adjuvants and myeloid-derived suppressor cells: enemies or allies in therapeutic cancer vaccination.
Fernández A; Oliver L; Alvarez R; Fernández LE; Lee KP; Mesa C
Hum Vaccin Immunother; 2014; 10(11):3251-60. PubMed ID: 25483674
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel promotes differentiation of myeloid-derived suppressor cells into dendritic cells in vitro in a TLR4-independent manner.
Michels T; Shurin GV; Naiditch H; Sevko A; Umansky V; Shurin MR
J Immunotoxicol; 2012; 9(3):292-300. PubMed ID: 22283566
[TBL] [Abstract][Full Text] [Related]
12. Diamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer Therapy.
Clappaert EJ; Murgaski A; Van Damme H; Kiss M; Laoui D
Front Immunol; 2018; 9():2250. PubMed ID: 30349530
[TBL] [Abstract][Full Text] [Related]
13. Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response.
Sinha P; Clements VK; Bunt SK; Albelda SM; Ostrand-Rosenberg S
J Immunol; 2007 Jul; 179(2):977-83. PubMed ID: 17617589
[TBL] [Abstract][Full Text] [Related]
14. Myeloid-derived suppressor cells: linking inflammation and cancer.
Ostrand-Rosenberg S; Sinha P
J Immunol; 2009 Apr; 182(8):4499-506. PubMed ID: 19342621
[TBL] [Abstract][Full Text] [Related]
15. Inflammation enhances myeloid-derived suppressor cell cross-talk by signaling through Toll-like receptor 4.
Bunt SK; Clements VK; Hanson EM; Sinha P; Ostrand-Rosenberg S
J Leukoc Biol; 2009 Jun; 85(6):996-1004. PubMed ID: 19261929
[TBL] [Abstract][Full Text] [Related]
16. Tolerance and immune suppression in the tumor microenvironment.
Ostrand-Rosenberg S
Cell Immunol; 2016 Jan; 299():23-9. PubMed ID: 26435343
[TBL] [Abstract][Full Text] [Related]
17. Targeting myeloid cells in the tumor sustaining microenvironment.
Schupp J; Krebs FK; Zimmer N; Trzeciak E; Schuppan D; Tuettenberg A
Cell Immunol; 2019 Sep; 343():103713. PubMed ID: 29129292
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral injection of CpG oligonucleotides induces the differentiation and reduces the immunosuppressive activity of myeloid-derived suppressor cells.
Shirota Y; Shirota H; Klinman DM
J Immunol; 2012 Feb; 188(4):1592-9. PubMed ID: 22231700
[TBL] [Abstract][Full Text] [Related]
19. [Immune system and tumors].
Terme M; Tanchot C
Ann Pathol; 2017 Feb; 37(1):11-17. PubMed ID: 28159405
[TBL] [Abstract][Full Text] [Related]
20. Tuning the Tumor Myeloid Microenvironment to Fight Cancer.
Jahchan NS; Mujal AM; Pollack JL; Binnewies M; Sriram V; Reyno L; Krummel MF
Front Immunol; 2019; 10():1611. PubMed ID: 31402908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
